Terns Pharmaceuticals, Inc. ( ($TERN) ) has released its Q4 earnings. Here is a breakdown of the information Terns Pharmaceuticals, Inc. presented ...

chief medical officer at Terns. “Additionally, we are excited to share new drug-drug interaction (DDI) data showing TERN-701 has a superior DDI profile compared to asciminib, allowing for safer ...

Detailed price information for Terns Pharmaceuticals Inc (TERN-Q) from The Globe and Mail including charting and trades.